Ixazomib, an oral proteasome inhibitor, induces rapid mobilization of hematopoietic progenitor cells in mice

Blood. 2018 Jun 7;131(23):2594-2596. doi: 10.1182/blood-2017-10-811620. Epub 2018 Apr 25.
No abstract available

Publication types

  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Administration, Oral
  • Animals
  • Boron Compounds / administration & dosage
  • Boron Compounds / pharmacology*
  • Glycine / administration & dosage
  • Glycine / analogs & derivatives*
  • Glycine / pharmacology
  • Hematopoietic Stem Cell Mobilization / economics
  • Hematopoietic Stem Cell Mobilization / methods*
  • Hematopoietic Stem Cells / cytology
  • Hematopoietic Stem Cells / drug effects*
  • Mice
  • Mice, Inbred BALB C
  • Proteasome Inhibitors / administration & dosage
  • Proteasome Inhibitors / pharmacology*
  • Time Factors

Substances

  • Boron Compounds
  • Proteasome Inhibitors
  • ixazomib
  • Glycine